Market Tracker

02/10 10:11am ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.66
BATS BZX Real-Time Price
As of 10:10am ET
 +0.22 / +4.04%
Today’s Change
5.10
Today|||52-Week Range
13.84
-28.35%
Year-to-Date

Today’s Trading

Previous close5.44
Today’s open5.50
Day’s range5.42 - 5.72
Volume1,216,422
Average volume (3 months)1,503,671
Market cap$628.7M
Dividend yield--
Data as of 10:10am ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-34.17%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+0.13+0.80%
CLLSCellectis SA+1.00+5.33%
FOLDAmicus Therapeutics ...+0.26+4.92%
SUPNSupernus Pharmaceuti...+0.77+6.35%
Data as of 10:10am ET, 02/10/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts